Clinical Trials Logo

Cancer clinical trials

View clinical trials related to Cancer.

Filter by:

NCT ID: NCT03644498 Completed - Cancer Clinical Trials

Study to Determine if the Flu Vaccine Increases the Risk of Muscle Damage in Participants Taking Drugs That Block Certain Proteins Made by Some Types of Immune System Cells

Start date: May 2, 2018
Phase:
Study type: Observational

A retrospective, observational study conducted on cancer patients receiving a drug that blocks certain proteins made by some types of immune system cells

NCT ID: NCT03641222 Completed - Pain Clinical Trials

Group Versus Individual Acupuncture for Cancer Pain

Start date: October 2, 2017
Phase: N/A
Study type: Interventional

Typically, in North America, acupuncture is performed on an individual basis. However, community acupuncture, also known as group acupuncture, is an emerging method of treating patients. Cancer patients, post-treatments were given acupuncture treatments to help alleviate pain, in a two-arm randomized trial.

NCT ID: NCT03640325 Active, not recruiting - Depression Clinical Trials

The Promoting Resilience in Stress Management (PRISM) Intervention: a Multi-site Randomized Controlled Trial for Adolescents and Young Adults Receiving Hematopoietic Cell Transplantation

Start date: April 1, 2019
Phase: Phase 3
Study type: Interventional

Multisite Randomized Controlled Trial (RCT) testing the efficacy of the Promoting Resilience in Stress Management (PRISM) intervention among Adolescents and Young Adults receiving hematopoietic cell transplantation for hematology malignancy.

NCT ID: NCT03634696 Completed - Cancer Clinical Trials

m-Palliative Care Link: Improving Palliative Care for Late Stage Tanzanian Cancer Patients

Start date: June 15, 2018
Phase: N/A
Study type: Interventional

This work aims to improve late-stage cancer patients' access to high quality, patient-centered symptom assessment and control via the creation, field test, and outcomes assessment of a scalable mobile application (mPalliative Care Link; mPCL)-built around a locally-validated Palliative care Outcome Scale- that links a limited pool of existing Tanzanian palliative care specialists with patients, lay/family caregivers, and local health workers.

NCT ID: NCT03632694 Completed - Cancer Clinical Trials

The Move for Your Health Pilot Study

Start date: July 6, 2016
Phase: N/A
Study type: Interventional

The Move for Your Health Pilot Study is a 16-week study in older cancer survivors to replace and break-up sedentary activity with short bouts of light physical activity.

NCT ID: NCT03628079 Terminated - Clinical trials for Cancer of the Gastrointestinal Tract

A Clinical Safety and Efficacy Study of Mebendazole on GI Cancer or Cancer of Unknown Origin.

RepoMeb
Start date: May 25, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

This study will evaluate the safety and efficacy of mebendazole (ReposMBZ) in patient with advanced gastrointestinal cancer or cancer of unknown origin. All patients will be given ReposMBZ for 16 weeks continuous treatment, individually dosed based on the serum concentration of mebendazole.

NCT ID: NCT03625947 Terminated - Cancer Clinical Trials

Efficacy and Safety of Argon Plasma Coagulation in the Treatment of Patients With Hemoptysis Caused by Endobronchial Malignancies

Start date: August 8, 2018
Phase:
Study type: Observational

The aim of this study is to evaluate the efficacy, the safety and the main predictors of success of bronchoscopic Argon Plasma Coagulation in patients with hemoptysis caused by endobronchial malignancies.

NCT ID: NCT03621813 Recruiting - Cancer Clinical Trials

Exercise Rehabilitation in Veteran Cancer Survivors

Start date: August 19, 2019
Phase: N/A
Study type: Interventional

Exercise rehabilitation has the potential as a non-pharmacological approach to reduce persistent neuropathic pain in Veterans with lung cancer. By examining the effects of exercise training in Veteran cancer survivors with NSCLC, there is the potential to revolutionize care for a: common, debilitating, and inadequately treated symptom in a growing population. This could lead to a larger investigation to fill critical gaps in the literature and at the same time help discover a new model of care for Veterans with chronic pain. The ultimate goal is to reduce this type of pain for the growing population of cancer survivors while simultaneously reducing the need for problematic opioid management.

NCT ID: NCT03617237 Recruiting - Cancer Clinical Trials

Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated With Radiation

Start date: July 3, 2012
Phase:
Study type: Observational

Registry database repository for determining clinical outcomes primarily of patients who have received or have been evaluated for radiation treatment in either the definitive or palliative setting for both malignant and benign etiologies. To compare the outcomes with National Cancer Data Base (NCDB) of the American College of Surgeon(ACS).

NCT ID: NCT03614650 Recruiting - Cancer Clinical Trials

Immunotherapy Treating GI Cancer

Start date: July 1, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

The primary objectives are to evaluate the safety and efficacy of infusion of autologous gastro-intestinal (GI) cancer antigen-specific engineered immune effector cells (EIE).